Your body relies on this gene to help make dermatan sulfate, a sugar chain that gives skin, joints, blood vessels, and other connective tissues strength and flexibility. If the CHST14 gene does not work properly, connective tissue can become unusually fragile, which may lead to easy bruising, stretchy or delicate skin, joint problems, and a genetic condition called musculocontractural Ehlers-Danlos syndrome. This gene plays an important role in how tissues keep their shape and handle everyday strain.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others mainly guide when, where, and how much certain body processes occur. In combination, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a more detailed explanation of this topic, you can find more in the LearnHub.
Overview
CHST14Gene function
What if the gene works
The CHST14 gene helps your body make dermatan sulfate, a sugar chain that supports connective tissue. This helps skin, joints, blood vessels, and other tissues stay strong and flexible.
Risk
What if the gene does not work
Variants in the CHST14 gene can cause musculocontractural Ehlers-Danlos syndrome, with fragile stretchy skin, easy bruising, and joints that are unusually loose or fixed in contractures. Milder and more severe variants can affect which features appear and how marked they are.
Treatment
What does that mean for your treatment
With a pathogenic or loss-of-function variant in the CHST14 gene, no CHST14-specific treatment or drug selection approach is currently established. Care is based on symptoms, and research is exploring connective tissue pathways rather than established targeted medicines.
Conditions associated with CHST14
Gene function
What if the gene works
Inside connective tissue, the CHST14 gene helps build a specific sugar chain called dermatan sulfate. This sugar chain attaches to proteins outside cells and supports the body’s natural framework. That role is central to what the CHST14 gene does in connective tissue, where strength and flexibility both matter.
The CHST14 gene adds sulfate tags to a sugar building block within dermatan sulfate. This helps the chain develop its usual structure and properties.
One of the main jobs of the CHST14 gene is to help produce mature dermatan sulfate on proteoglycans (proteins with attached sugar chains). These molecules are important parts of connective tissue.
Through dermatan sulfate, the CHST14 gene helps collagen fibers line up and pack together in an orderly way. This supports the normal structure of skin, tendons, ligaments, and blood vessel walls.
What is a variant?
Genetic variants are small differences in a gene’s DNA sequence. They are common and help explain normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works enough to contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
In terms of how variants influence the CHST14 gene's function, some changes stop the protein from being made, while others create an unstable protein with only partial activity. This can reduce the production of properly sulfated (chemically finished) dermatan sulfate, a sugar chain that helps organize connective tissue between cells. Milder variants may leave some residual activity, but more disruptive variants often cause near-complete loss of function and are usually linked to earlier or more marked features of CHST14-related musculocontractural Ehlers-Danlos syndrome.
How variants are linked to conditions
Disease-causing variants in the CHST14 gene cause musculocontractural Ehlers-Danlos syndrome, a rare inherited connective tissue condition. This form of Ehlers-Danlos syndrome is linked to fragile or stretchy skin, easy bruising, joint looseness, and hand or foot differences that are often present from birth. Finding disease-causing variants in both copies of the CHST14 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and form a normal part of human biology. Most of them do not directly affect health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some cases, however, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHST14, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having the condition is higher when both parents carry a changed CHST14 gene, so family history and parents being blood relatives can increase the chance in a pregnancy.
Inheritance of CHST14 variants
CHST14-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one CHST14 gene variant from each parent, and both parents are often healthy carriers. When two carriers have a child together, each pregnancy has a 25% chance of the child inheriting both variants, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, the CHST14 inheritance pattern affects sons and daughters equally.
What does my CHST14 result mean for my family?
For families with a CHST14-related condition, close relatives may also carry the changed gene, even if they have no symptoms. Brothers and sisters may be affected or may be carriers, and other relatives may also carry the same change. This can be useful information for family planning and for relatives who want to understand their own chances of having an affected child.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the CHST14 gene, genetic testing for CHST14 variants uses a blood, saliva, or cheek swab sample. A laboratory reads the DNA code in the gene and checks for changes, including a known family variant or variants linked with a CHST14 related condition.
When should I consider getting a genetic test?
Genetic testing for the CHST14 gene may be worth considering when a child or adult has signs of musculocontractural Ehlers-Danlos syndrome, such as very fragile, stretchy skin, easy bruising, unusually loose joints, and birth contractures like clubfoot. It can also help when this condition is already known in the family.
A genetic result is only one part of your health story
A genetic result may provide useful insight, but how much it reveals varies by the condition and the specific type of variant. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, these results may help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work differently from one person to another. Some variants change how quickly a drug is broken down or moved through the body. This can influence how much benefit a medicine gives or how likely side effects are. These differences are common and are one reason medication response is not exactly the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medication. It focuses on links between genes and drugs to better explain why the same treatment may work differently from one person to another. For many medications, genes influence how strongly a drug works or how the body handles it. This information can support more informed and more individualized treatment decisions. If you want to learn more about this topic, you can read further in the LearnHub.
Drugs influenced by the CHST14 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any concerns about symptoms, side effects, or treatment are best discussed with your doctor.
History
Throughout history, people described inherited patterns of fragile skin, joint laxity, and birth contractures long before the cause was known. Scientific classifications changed as researchers learned more about the gene. In the late 2000s, researchers linked this form of Ehlers-Danlos syndrome to variants in the CHST14 gene, first reported as a condition called D4ST1 deficiency. From these first observations, research expanded steadily. Doctors later brought these cases into the modern Ehlers-Danlos framework, now known as musculocontractural Ehlers-Danlos syndrome. This historical shift helped unify older clinical descriptions with genetic testing and made diagnosis more precise for affected families.